Deep Tech Startups

Cellid is a fabless company developing AR glasses displays (waveguides) and spatial recognition engines for next-generation devices. It works with major domestic and international manufacturing partners to build a production ecosystem for mass-producing its waveguides.

4 investors

CELUS provides AI-driven automation software for electronics engineering, helping engineers design and develop electronic circuits faster. It targets electronics design and hardware engineering teams.

4 investors

Cerabyte develops long-term, sustainable data storage technology aimed at preserving digital records permanently. It positions itself as an archival data storage company.

4 investors

Ceregate develops brain-computer interface and neuromodulation technologies to improve patient outcomes in neurodisorders. The company brings together expertise in neuroscience, engineering, and medical devices to advance non-invasive neuromodulation solutions.

4 investors

ChemFinity Technologies develops highly selective sorbent and membrane materials for molecular separations used in resource recovery, including extracting critical minerals, metals, and water from waste streams. The company focuses on scaling these materials from lab to pilot and industrial deployment for sustainability and energy-efficiency applications.

4 investors

Chiral develops electron spin alignment technologies and applications based on the CISS effect to reduce resistivity and overpotential waste, enabling sustainable and higher-performance solutions.

4 investors

Cime Therapeutics is developing a chemistry-first drug discovery platform that combines automation, AI/ML, and synthetic chemistry to make molecules faster and more cost-effectively. The platform integrates the synthesis and screening stages to accelerate the Design-Make-Test-Analyze cycle in pharmaceutical discovery.

4 investors

CircuitLeap builds GPU-native, multi-PDK electronic design automation (EDA) software for analog and heterogeneous IC design, covering schematic, 3D layout, and simulation across dies, packages, and boards. It targets chip design teams, offering AI-based analog layout generation and a plugin that integrates with existing EDA environments for signoff.

4 investors

Cleara Biotech develops compounds to eliminate senescent cells for treating late-stage cancer and chronic age-related diseases. The company translates academic research on cellular senescence into clinical therapeutics.

4 investors

Climeworks develops Direct Air Capture technology to remove carbon dioxide directly from the air, and through Climeworks Solutions designs and manages carbon removal portfolios that combine engineered and nature-based methods. It serves organizations seeking carbon removal, including compliance-ready offerings.

4 investors

Clockwork Labs is a game studio building massively-multiplayer "societal games" that emphasize social interaction and cooperation over combat. It develops technology for large-scale sandbox virtual worlds and distributed systems to support these games.

4 investors

Coagulo develops a portable point-of-care testing platform for coagulation disorder diagnosis and management using microfluidic technology and data analytics. The platform enables healthcare providers to perform comprehensive coagulation testing with drops of blood and deliver results within 10 minutes.

4 investors

Coave Therapeutics develops targeted gene therapy vectors using its proprietary ALIGATER platform to deliver therapeutic genes to specific tissues with improved safety and precision. The company focuses on treating retinal vascular diseases and other genetic conditions where traditional gene therapy delivery has been limited.

4 investors

Combinati developed the QuantStudio Absolute Q Digital PCR System, which uses microfluidic array plate (MAP) technology for detection and quantification of nucleic acids, rare mutations, and genome editing events. The platform serves research laboratories for applications such as next-generation sequencing library quantification and CRISPR-Cas9 editing analysis.

4 investors

Congruence is a drug discovery company that applies protein dynamics, biophysics, machine learning, and computational chemistry to model proteins in their full dynamic state and predict disease correction in silico. It uses these computational methods to identify and design therapeutics.

4 investors

Conifer designs and manufactures powertrains and motors for drones, robots, data centers, and mobility applications using proprietary axial-flux architecture that reduces material costs and increases performance. The company prioritizes supply chain independence through the use of globally abundant magnets.

4 investors

Constellation provides an operations platform designed for satellite fleet management that ingests telemetry data, executes machine learning predictions, and automates decision-making based on operator policies.

4 investors

Contactile develops tactile sensor technology, including the PapillArray tactile sensor arrays that measure 3D displacement, force, vibration, torque, slip, and friction, along with force/torque sensors and two-finger grippers. Its products target robotics, prosthetics, industrial handling, and research applications across manufacturing, logistics, healthcare, and other sectors.

4 investors

Cool Planet Technologies develops a membrane-based process for capturing carbon dioxide from industrial flue gas emissions, targeting industrial emitters including hard-to-abate sectors. The company designs, builds and sells carbon capture solutions to help companies meet net zero commitments.

4 investors

Coolit Systems provides liquid cooling solutions for data centers, addressing thermal management challenges in modern computing infrastructure.

4 investors

Core Biogenesis is a French biotech that uses an oleosome fusion platform to grow active peptides and proteins (such as EGF and FGF-2) inside camelina seeds, producing formulation-ready topical delivery carriers for skin and scalp. It supplies these recombinant protein actives to the cosmetics and personal care industry, serving formulators, R&D teams, and brands.

4 investors

CorPower Ocean develops wave energy converters that transform ocean waves into electricity through biologically-inspired technology. The company operates in the renewable energy sector, targeting commercial-scale wave energy deployment globally.

4 investors

CorrActions develops NeuroMonitor, a software-only system that detects driver and passenger cognitive states such as alcohol impairment, fatigue, and inattention using data already available in vehicles, deployed via over-the-air updates without hardware changes. It serves automotive safety partners and OEMs, positioning itself in the driver monitoring and road safety category.

4 investors

Cradle uses AI to help scientists design and engineer proteins, decoding and rewriting biology to develop new food sources, materials, and therapeutics. It serves research scientists and offers models validated in its own lab before delivery to customers.

4 investors